cinnamyl isobutyrate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5355851 |
| CHEBI ID | 195937 |
| SCHEMBL ID | 827613 |
| MeSH ID | M0078106 |
| Synonym |
|---|
| cinnamyl isobutyrate |
| 103-59-3 |
| nsc-46133 |
| isobutyric acid, cinnamyl ester |
| nsc46133 |
| propanoic acid, 3-phenyl-2-propenyl ester |
| einecs 203-126-6 |
| 3-phenyl-2-propen-1-yl isobutyrate |
| 2-methyl-propanoic acid, 3-phenyl-2-propenyl ester |
| 3-phenyl-2-propen-1-yl 2-methylpropanoate |
| cinnamyl 2-methylpropanoate |
| fema no. 2297 |
| nsc 46133 |
| brn 3130772 |
| ai3-24262 |
| propanoic acid, 2-methyl-, 3-phenyl-2-propenyl ester |
| cinnamyl isobutyrate, >=97%, fcc, fg |
| 3-phenylprop-2-en-1-yl 2-methylpropanoate |
| CHEBI:195937 |
| [(e)-3-phenylprop-2-enyl] 2-methylpropanoate |
| propanoic acid, 2-methyl-, 3-phenyl-2-propen-1-yl ester |
| tox21_302702 |
| dtxcid4027608 |
| dtxsid6047608 , |
| NCGC00256924-01 |
| cas-103-59-3 |
| cinnamyl isobutyrate [fhfi] |
| C286CMK03D , |
| cinnamyl isobutyrate [fcc] |
| 110682-09-2 |
| SCHEMBL827613 |
| unii-c286cmk03d |
| AKOS024437456 |
| cinnamyl iso-butyrate |
| (2e)-3-phenyl-2-propenyl 2-methylpropanoate # |
| KLKQSZIWHVEARN-RMKNXTFCSA-N |
| cinnamyl isobutyrate, analytical standard |
| Q27275092 |
| AS-57396 |
| cinnamylisobutyrate |
| Class | Description |
|---|---|
| styrenes | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 70.9799 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 24.3365 | 0.0007 | 14.5928 | 83.7951 | AID1259369; AID1259392 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 4.3647 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.20) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (14.29%) | 5.53% |
| Reviews | 2 (28.57%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (57.14%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||